pioglitazone
06-009A
Approved small_molecule completed
Quick answer
pioglitazone for Type 2 Diabetes Mellitus is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed